Acerus to Report 2019 Financial Results

TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB : ASPCF) will announce financial results for the three and twelve month periods ending December 31, 2019 on Wednesday, March 4, 2020 before the market opens.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of innovative, branded products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in Canada, and through a global network of licensed distributors in the U.S. and other territories.

Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200226005662/en/

Acerus Pharmaceuticals Corporation
Robert Motz
Chief Financial Officer
[email protected]
(905) 817-8288

Source: Acerus Pharmaceuticals Corporation

You May Also Be Interested In

• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
• KBRA Affirms Ratings for Banner Corporation
• How Diana Ulis and Other South Florida Developers Are Redefining What Luxury Actually Means